Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 7:28-31.

[Renin inhibition and the kidney].

[Article in Turkish]

Author information

  • Department of Internal Medicine, Istanbul Medicine Faculty of Istanbul University, Istanbul, Turkey. ecder@istanbul.edu.tr

Abstract

Renin-angiotensin aldosterone system has a detrimental effect on the progression of renal failure in patients with chronic kidney disease. Drugs inhibiting the renin-angiotensin aldosterone system, such as angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers have been shown to slow the progression of kidney disease in patients with diabetic and nondiabetic renal diseases. Aliskiren is a direct renin inhibitor that blocks the renin-angiotensin system at its initial step. Several experimental studies have demonstrated the renoprotective effects of aliskiren. Aliskiren, added to standard therapy, shows additional and significant antiproteinuric effects in patients with diabetic nephropathy. The optimal therapeutic approach to patients with target organ damage will be better understood as the ongoing large clinical studies with direct renin inhibitors conclude.

PMID:
20019474
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk